METRONIDAZOLE BAXTER 0.5 %, solution for injection in a bag 60 bags of 100 ml
Active ingredients: Metronidazole
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection60 bags of 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METRONIDAZOLE BAXTER 0,5 POUR CENT, solution injectable en poche
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 60 poche(s) (VIAFLO) polyéthylène polyamide polypropylène de 100 ml
- Marketing authorisation holder
- BAXTER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Feb 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65687841CIP75505523CIP133400955055235Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTRONIDAZOLEsolution | 500 mg · une poche | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.